ISMICS Home  |  Past & Future Meetings
Countdown to ISMICS : 44 Days  
International Society For Minimally Invasive Cardiothoracic Surgery

Back to 2021 Cardiac Abstracts


Minimally Invasive Surgery Versus Sternotomy Approach In Mitral Valve Redo
Erik Cura Stura, Claudia Calia, Cristina Barbero, Giovanni Marchetto, Marco Pocar, Massimo Boffini, Mauro Rinaldi.
Cittą della Salute e della Scienza di Torino - Molinette, Torino, Italy.

BACKGROUND: Redo mitral valve surgery performed through median sternotomy is associated with significant mortality and morbidity. Minimally invasive surgery (MIS) through right mini-thoracotomy allows the surgeon to avoid re-entry injuries and related complications.
METHODS: From January 2006 to January 2019, 423 redo mitral valve procedures were performed in our department: 134 (31.7%) with sternotomy approach and 289 (68.3%) MIS through right mini-thoracotomy.
RESULTS: The two groups (sternotomy vs MIS) differ in logistic EuroSCORE (25.4±19.7 vs 19.0±16.4, p=0.004), number of previous surgeries (1.2±0.6 vs 1.4±0.8, p=0.005), urgency (20.9 % and 6.6 %, p 0.001) and PAPS (56.2 ± 15.9 vs 50.1 ± 16.0, p 0.003). The cannulation chosen was considerably different in the two cohorts and tailored on patient characteristics. In MIS the preferred cannulation setting was the peripheral with endoclamp (78.2%); peripheral with transthoracic clamp was used in 7.3% and with endodirect clamp in 5.9%. In sternotomy group central cannulation was preferred (88.1%) while peripheral was used only in 10.5%. Fibrillating heart technique was use only in MIS group (8.0%). Aortic cross clamp time was significantly longer in sternotomy (98.6±31.3 vs 89.5±28.5, p< 0.05), while there was no difference in cardiopulmonary bypass time (137.8 ± 47.0 vs 139.2 ± 47.4, p 0.87). Mean intubation time (14 vs 12 h, p < 0.05) and ICU stay (48 vs 24 h, p 0.03) were lower in MIS group. Early postoperative complications were comparable in the two groups except for higher rate of blood transfusion (p<0.0001), tracheostomy (p=0.026) and new onset of atrial fibrillation (p<0.0001) in sternotomy cohort. No significant difference was reported in 30-day mortality (8.2% vs 5.9%, p 0.24). Higher freedom from reoperation (at 8 years 95% vs 83 %, p 0.01) and survival rate (at 5 years 80% vs 89%; at 12 years 60% vs 75% p 0.04) was observed in the MIS cohort.
CONCLUSIONS: MIS allows excellent results in high risk patients as redo mitral valve surgery



Back to 2021 Cardiac Abstracts
By using this site, you agree to our updated Privacy Policy.  Got it